VYNT - Vyant Bio Inc
Previous close
0.194
0 0%
Share volume: 19,116
Last Updated: Fri 29 Dec 2023 06:00:00 AM CET
Medical Laboratories :
-2.05%
PREVIOUS CLOSE
CHG
CHG%
$0.19
0.00
0.00%
Fundamental analysis
40%
Profitability
50%
Dept financing
0%
Liquidity
0%
Performance
50%
Performance
5 Days
12.46%
1 Month
9.30%
3 Months
14.12%
6 Months
-3.00%
1 Year
-22.40%
2 Year
-22.40%
Key data
Stock price
$0.19
DAY RANGE
$0.19 - $0.19
52 WEEK RANGE
$0.14 - $0.35
52 WEEK CHANGE
-$0.22
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: John Roberts
Region: US
Website: http://www.cancergenetics.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Medical Laboratories
Sector: Health Care and Social Assistance
Region: US
Website: http://www.cancergenetics.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Medical Laboratories
Sector: Health Care and Social Assistance
vyant bio (nasdaq: vynt) - uniting human biology, engineering, data science, and passion to transform lives
Recent news